Received Oct 9, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| COVID19 | COVID19 (COVID19 (MODERNA)) | MODERNA | 5 | — | IM |
she has had some long COVID effects; This spontaneous case was reported by a consumer and describes the occurrence of POST-ACUTE COVID-19 SYNDROME (she has had some long COVID effects) in a 75-year-old female patient who received SPIKEVAX NOS (SPIKEVAX NOS) for COVID-19 prophylaxis. Previously administered products included for Product used for unknown indication: Flu shot; for COVID-19 prophylaxis: Spikevax NOS (Previous 3 doses). Past adverse reactions to the above products included No adverse effect with Flu shot and Spikevax NOS. On an unknown date, the patient received fourth dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) .5 milliliter. On an unknown date, received fifth dose of SPIKEVAX NOS (SPIKEVAX NOS) (Intramuscular use) dosage was changed to .5 milliliter. In 2023, the patient experienced POST-ACUTE COVID-19 SYNDROME (she has had some long COVID effects). At the time of the report, POST-ACUTE COVID-19 SYNDROME (she has had some long COVID effects) outcome was unknown. No concomitant medication was reported. The patient was not planning to originally get the regular COVID vaccine, but since there was a new one, a lower dose for seniors, she was willing to try it. She was very petite and had chronic fatigue after her last two COVID boosters. She wasn't going to have one this year, but she felt anxious about not having one, because she had all 5 priors. All of her Covid vaccines prior to that with no side effects. But last year and the year before, she had some long COVID effects, and she wasn't going to get one at all. But since there was one that's like 1/5 the dose of the regular, she's going to try. It was unknown if the patient experienced any additional symptoms/events. No treatment medication was reported. Reporter did not allow further contact